Search Results for keywords:"DEA registration revocation"

The Drug Enforcement Administration (DEA) issued an order to revoke the registration of Dr. Ajumobi Agu in Nevada due to violations of the Controlled Substances Act (CSA). Dr. Agu continued prescribing controlled substances even after his state medical and controlled substances licenses were suspended. The DEA concluded that his actions are inconsistent with the public interest and deemed him untrustworthy to handle such substances. As such, Dr. Agu will be unable to apply to renew or modify his DEA registration, effective May 16, 2025.

The Drug Enforcement Administration (DEA) has revoked Samreen Riaz, D.D.S.'s registration to handle controlled substances due to her lack of authority to practice dentistry in California, where her DEA registration was held. The decision was made following the Dental Board of California's revocation of her dental license, effective September 1, 2023. Riaz did not respond to the Order to Show Cause (OSC), resulting in her default and the revocation of her DEA registration. The DEA's action ensures that individuals without the necessary state licenses cannot handle controlled substances, maintaining compliance with federal regulations.

The Drug Enforcement Administration (DEA) issued an Order to Show Cause to Linwood A. Starks, D.V.M., proposing to revoke his Certificate of Registration because he is not authorized to handle controlled substances in Texas due to the suspension of his veterinary license. Starks requested a hearing but failed to respond to the allegations, leading to a termination of proceedings and his default. As a result, the DEA Administrator decided to revoke his registration and deny any future applications, as maintaining a DEA registration requires state authorization to handle controlled substances. This decision takes effect on April 21, 2025.

The Drug Enforcement Administration (DEA) sought to revoke two registrations of Jason Weakley, a registered nurse and advanced practice registered nurse, because he was not authorized to handle controlled substances in Vermont and New Hampshire. Weakley's nursing licenses in both states had expired and remained suspended. He was informed of his right to a hearing but did not request one, leading to a default judgment against him. Consequently, the DEA revoked his registrations, preventing him from handling controlled substances and from renewing or applying for new registrations in these states.

The Drug Enforcement Administration (DEA) revoked the registration of Hazem Barmada, M.D., allowing him to handle controlled substances in Mississippi because he no longer has a valid medical license in the state. The Mississippi State Board of Medical Licensure had accepted his voluntary surrender of the license in 2021, making him ineligible to practice medicine and handle controlled substances there. As holding a valid state license is necessary for DEA registration, Dr. Barmada’s registration was revoked, and any pending applications related to it were denied. This decision will take effect on April 21, 2025.

The Drug Enforcement Administration (DEA) has revoked the DEA registration of Xubex Community Pharmacy in Casselberry, Florida. This decision was made because the pharmacy dispensed controlled substances, specifically Schedule II drugs like oxycodone and hydromorphone, without prescriptions. The DEA considered these actions a threat to public health and safety, demonstrating that the pharmacy cannot be trusted to comply with legal requirements. Furthermore, the pharmacy did not request a hearing to dispute these conclusions, leading to the default revocation of its registration.

The Drug Enforcement Administration (DEA) is revoking the registration of Dr. Harvey Leslie, which allowed him to handle controlled substances. This is because his medical license in Georgia has been revoked, and he can no longer practice medicine or legally handle controlled substances there. Since having a valid state license is necessary to maintain DEA registration for handling controlled substances, Dr. Leslie's registration is being revoked, effective April 28, 2025. The decision was signed by the Acting Administrator, Derek Maltz, on March 20, 2025.

The Drug Enforcement Administration (DEA) issued an order to revoke Maria Dewitt's registration to handle controlled substances because she lacks the necessary authorization in Texas. Dewitt did not have a required prescriptive authority delegation agreement with a physician, which is essential for an advanced practice registered nurse in Texas to manage controlled substances. The administrative law judge upheld this decision, noting that without state authorization, Dewitt could not maintain her DEA registration. Consequently, her registration was revoked, and any further applications for registration in Texas were denied.

The Drug Enforcement Administration (DEA) decided to revoke the registration of Neumann's Pharmacy, LLC, after finding that it repeatedly failed to ensure controlled substance prescriptions were issued for legitimate medical purposes and did not document resolutions of red flags like drug interactions and cash payments. The pharmacy also improperly filled prescriptions written by the owner’s father, which violates Louisiana law. Despite given opportunities, the pharmacy did not fully acknowledge its mistakes or demonstrate it corrected them, leading to concerns about its ability to responsibly handle controlled substances in the future. The agency emphasized the importance of deterrence and the severity of the misconduct, ultimately leading to revocation of the pharmacy's DEA registration.

The Drug Enforcement Administration (DEA) has decided to revoke Joely Keen's DEA registration because she is no longer authorized to handle controlled substances in Texas. Her licenses to practice as an advanced practice registered nurse (APRN) and registered nurse in Texas have been revoked, and she lacks a necessary prescriptive authority agreement with a supervising physician. Without these, she cannot legally prescribe or dispense controlled substances, resulting in the loss of her DEA registration. The order becomes effective on April 28, 2025.